Genentech
Pioneering Biotechnology Since 1976
About Genentech
Funding & Growth
✓ Pros
- • Industry-leading compensation and benefits
- • Cutting-edge science with real patient impact
- • Excellent work-life balance for pharma
- • Beautiful South SF campus
- • Strong internal mobility and career growth
- • Publication-friendly culture
- • Roche stability with biotech innovation
✗ Cons
- • Large company with some bureaucracy
- • Some Roche integration friction
- • Bay Area cost of living
- • Competitive internal transfers
- • Long timelines for drug development
🏢 Working Here
Genentech is the birthplace of the biotechnology industry and consistently ranks among the best places to work in biopharma.
The South San Francisco campus offers stunning Bay views, on-site amenities, and a collaborative atmosphere.
Bioinformatics teams are embedded across Therapeutic Areas (oncology, immunology, neuroscience) and platform groups (computational biology, data science, research IT).
Work ranges from early discovery (target identification, MOA studies) to clinical development (biomarker analysis, companion diagnostics).
The culture balances scientific rigor with business impact.
Unlike pure pharma, Genentech maintains a startup mentality with regular hack days and innovation time.
Collaboration between computational and wet-lab scientists is highly valued.
Compensation is exceptional - base salaries are top-tier, with generous bonuses (15-25%) and stock/equity.
Benefits include sabbaticals, education reimbursement, and excellent healthcare.
🧬 Bioinformatics Focus
Genentech's computational biology spans the entire drug development pipeline:
- Target Discovery - Large-scale genomics (GWAS, eQTL), functional genomics (CRISPR screens), and multi-omic integration to identify drug targets.
- Translational Research - Biomarker discovery, patient stratification, and companion diagnostic development for clinical trials.
- Single - Cell & Spatial - Industry-leading single-cell capabilities (dissociation, sequencing, analysis) and spatial transcriptomics for tissue biology.
- Machine Learning - Deep learning for drug response prediction, image analysis, and molecular property prediction.
- Clinical Genomics - NGS panel development, ctDNA analysis, and real-world evidence integration. Key groups include Computational Sciences, Translational Oncology, and the Digital Innovation Lab.
📈 Career Growth & Development
Career Paths
Individual Contributor
Management
Top Compensation
Base + 15-25% bonus + equity. Principal Scientists earn $200K-280K+. Distinguished Scientists approach $400K total comp.
Clear Progression
Well-defined levels with competency matrices. Typical progression: 2-3 years per level with strong performance.
Internal Mobility
Move between oncology, immunology, neuroscience, or into clinical/commercial. Lateral moves are encouraged.
Work-Life Balance
Flexible hours, remote options, and strong PTO. Sabbatical available after 6 years.
💊 Top Medicines & Blockbuster Drugs
Herceptin
1998Indication: HER2+ Breast Cancer
$7B+ peak sales
Avastin
2004Indication: Multiple Cancers (anti-VEGF)
$7B+ peak sales
Tecentriq
2016Indication: PD-L1 Immunotherapy
$4B+ annual
Ocrevus
2017Indication: Multiple Sclerosis
$6B+ annual
Phesgo
2020Indication: HER2+ Breast Cancer (SC)
Growing